Cargando…
Nebulized Heparin for Post-COVID-19-Related Hypoxia
Autores principales: | Hursitoglu, Mehmet, Eroz, Erhan, Ozgul, Mehmet Akif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324424/ https://www.ncbi.nlm.nih.gov/pubmed/34377888 http://dx.doi.org/10.1055/s-0041-1732340 |
Ejemplares similares
-
Evaluation of the Prevalence of Barotrauma and Affecting Factors in Patients with COVID-19 during Follow-Up in the Intermediate Care Unit
por: Bahadir, Ayse, et al.
Publicado: (2022) -
Nebulized Heparin in Burn Patients with Inhalation Trauma—Safety and Feasibility
por: Glas, Gerie J., et al.
Publicado: (2020) -
Nebulized Heparin to Reduce COVID-19-induced Acute Lung Injury: A Prospective Observational Study
por: Gupta, Bhavna, et al.
Publicado: (2023) -
Role of Nebulized Heparin in Clinical Outcome of COVID-19 Patients with Respiratory Symptoms: A Systematic Review
por: Gupta, Bhavna, et al.
Publicado: (2023) -
A phase 1 trial of nebulized heparin in acute lung injury
por: Dixon, B, et al.
Publicado: (2008)